Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 95/100

Q4 2019 Torrent Pharmaceuticals Ltd Earnings Call Transcript

May 20, 2019 / 01:00PM GMT
Operator

Good evening, ladies and gentlemen, and welcome to Q4 FY '19 earnings call of Torrent Pharmaceuticals Limited.

We have with us, Sri Sanjay Gupta, Executive Director, International Business; Sri Dhruv Gulati, Executive Director India and ROW Business; and Sri Sudhir Menon, CFO, who will represent Torrent Pharmaceuticals on the call.

(Operator Instructions)

Please note that this conference is being recorded.

I now hand the conference over to Sri Sanjay Gupta for opening remarks. Thank you, and over to you, sir.

Sanjay Gupta
Torrent Pharmaceuticals Limited - Executive Director of International Business

Thank you, and good evening, everyone, and welcome to the financial year '19 conference call.

I will start with the Q4 results. Q4 revenues were up by 9% at INR 1,856 crores. Q4 EBITDA margin before exceptional items was at 26%. For the full fiscal year, revenues were at INR 7,673 crores with a year-on-year growth of 29%. The Board of Torrent Pharma has recommended a final dividend of INR 54 per equity share.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot